Russell Investments Group
BOLD

Russell Investments Group’s Boundless Bio BOLD Stock Holding History

Russell Investments Group’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-265
Closed -$400 – 3974
2025
Q1 		$400 Sell
265
-291
-52% -$603 ﹤0.01% 3694
2024
Q4 		$1.61K Buy
556
+507
+1,035% +$1.48K ﹤0.01% 3476
2024
Q3 		$170 Buy
+49
New +$178 ﹤0.01% 3651

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's BOLD Position: Q2 2025 in Review

Russell Investments Group sold out of Boundless Bio (BOLD) in Q2 2025, closing a stake of 265 shares — an estimated $400 sold.

Russell Investments Group first reported a position in BOLD in Q3 2024 and held it in 3 quarters. The position peaked at $1.61K in Q4 2024. 44 funds tracked by Wall St. Rank hold BOLD as of Q2 2025.

  • Russell Investments Group reported no remaining Boundless Bio position as of Q2 2025 after selling out during the quarter.
  • Russell Investments Group sold 265 Boundless Bio shares in Q2 2025, an estimated $400.
  • Russell Investments Group first reported a position in Boundless Bio in Q3 2024 and held it in 3 quarters.
  • Russell Investments Group's Boundless Bio position peaked at $1.61K in Q4 2024.
  • 44 funds tracked by Wall St. Rank held Boundless Bio as of Q2 2025.

Based on Russell Investments Group's 13F filing for Q2 2025, filed 13 Aug 2025.